Stephen Mburu | Clinical chemistry | Best Researcher Award

Posted on by ScienceFather

Mr. Stephen Mburu | Clinical chemistry | Best Researcher Award

Mr. Stephen Mburu, Kenyatta University, Kenya

Stephen Mburu is a highly dynamic and self-driven Medical Laboratory Scientist with expertise in Medical Laboratory Management and Molecular Testing. He has extensive experience in specimen collection, processing, and implementing Quality Management Systems (QMS). With a strong background in blood sample collection and handling, he ensures adherence to Standard Operating Procedures (SOPs). Stephen is committed to creating an impactful environment for both personal and organizational growth, demonstrating excellent teamwork, communication, and analytical skills. He is currently advancing his career as a Medical Laboratory Superintendent and Trainer, mentoring medical students and leading various health initiatives. 👨‍🔬💼📊

Publication Profile

Orcid

Education

Stephen is currently pursuing a Master’s degree in Medical Laboratory Sciences (Clinical Chemistry/Biochemistry) at Kenyatta University, building on his Bachelor of Science in Medical Laboratory Sciences from Kenya Methodist University. He also holds certifications in computer packages and several medical laboratory-related training programs. His educational background and ongoing studies enable him to stay up to date with industry standards and practices, while also enhancing his capabilities in laboratory management, data analysis, and research. 🎓🔬📚

Experience

Stephen has accumulated comprehensive experience in medical laboratory sciences through roles such as a Medical Laboratory Superintendent at Thika Nursing Home Hospital and a Medical Laboratory Technologist at Thika School of Medical and Health Sciences. His expertise includes implementing Quality Management Systems, managing laboratory operations, conducting molecular tests, and mentoring students. Stephen has led various projects, including ensuring a 100% student pass rate in national exams and introducing new courses like the Certificate in Safe Phlebotomy, which saw 80% enrollment. His experience reflects a commitment to quality and continuous improvement in healthcare delivery. 🏥💼👨‍🔬

Awards and Honors

Stephen has received notable recognition for his exceptional contributions to medical laboratory science. He led his department’s successful accreditation by HUQAS Lab systems and played a key role in achieving a 100% student pass rate in national KMLTTB exams. Additionally, he introduced a short course on safe phlebotomy at Thika School of Medical and Health Sciences, which resulted in significant enrollment. His leadership and commitment to academic and operational excellence have earned him respect within the healthcare and education sectors. 🏅🎖️📜

Research Focus

Stephen’s research focuses on antimicrobial susceptibility testing, particularly on E. coli in children under five at Meru Level Five Teaching and Referral Hospital. His academic and research interests include molecular diagnostics, quality management systems in laboratories, and the development of innovative training programs for medical students. His work aims to contribute to improved healthcare delivery through advanced laboratory techniques and evidence-based practices. Stephen is committed to advancing the fields of molecular testing and laboratory management, ensuring accurate and reliable healthcare diagnostics. 🧬🔬

Publication Top Notes

Cardioprotective and anti-atherosclerotic effects of Rhamnus prinoides extracts in animal models

Mai O. Kadry | Molecular Biology | Best Researcher Award

Posted on by ScienceFather

Assist. Prof. Dr. Mai O.Kadry | Molecular Biology | Best Researcher Award

Assist. Prof. Dr. Mai O.Kadry,National Research Center, Egypt

Dr. Mai Osman Mohamed Kadry is a distinguished biochemistry researcher at the Therapeutic Chemistry Department, National Research Centre, Egypt. With a Doctorate in Biochemistry from Cairo University (2016), her work focuses on oxidative injury, nanotoxicity, and cancer therapy. She has published extensively in high-impact journals on topics like antioxidant effects, stem cell therapies, and metabolic disorders. Dr. Kadry has also contributed to academia, teaching pharmacognosy at 6th October University. Skilled in advanced techniques like PCR, HPLC, and ELISA, she actively participates in groundbreaking nanobiotechnology research projects. Dr. Kadry is committed to advancing therapeutic strategies for critical diseases. 📚🧬

Publication Profile

Scopus

Academic and Professional Experience 🌟🎓

Assist. Prof. Dr. Mai O. Kadry has accumulated valuable experience in academia and research. She served as a pharmacognosy instructor at the Faculty of Pharmacy, 6th October University, Cairo, Egypt (2003–2004), where she effectively delivered courses on natural products and their therapeutic applications. Dr. Kadry also contributed as a staff member focused on development and quality enhancement, aligning with the standards of the National Commission for Academic Accreditation. Her dedication to education and quality assurance reflects her commitment to fostering academic excellence and professional growth in pharmaceutical sciences. 📚🔬

 

Educational Background 🎓📘

Assist. Prof. Dr. Mai O. Kadry boasts a strong academic foundation in pharmaceutical sciences. She earned her Doctorate in Biochemistry from the Faculty of Pharmacy, Cairo University, in 2016, with a thesis on the “Amelioration of Nano-Sized Titanium Dioxide-Induced Oxidative Injury in Mice by Some Antioxidants.” She obtained her Master’s degree in Pharmaceutical Sciences from Helwan University in 2008, focusing on the synergistic effects of phytic and catechin on carbon tetrachloride-induced damage in rats. Dr. Kadry completed her B.Sc. in Pharmaceutical Science at Ain Shams University in 2003, graduating with honors. She also attended English language schools, enhancing her global communication skills. 🌟🔬

 

Training 🧬📚

Assist. Prof. Dr. Mai O. Kadry has undergone extensive training in various scientific disciplines. She completed courses in Biostatistics (November 2016) and Bioinformatics (January 2017) at the National Research Centre. Earlier, she gained expertise in Scientific Typewriting Bases (March 2007) and Occupational Health and Safety (June 2009). Additionally, she mastered Protein Electrophoresis through a four-month course in 2006. Dr. Kadry enhanced her practical skills with hands-on training at Al-Borg Clinical Laboratory, focusing on PCR techniques for detecting HBV and HCV at the Theodor Bilharz Research Institute. Her comprehensive training equips her with valuable laboratory and analytical skills. 🔬🧪

 

Research Focus 🧪🧠🧬

Assist. Prof. Dr. Mai O. Kadry focuses on cutting-edge biomedical research, emphasizing toxicity, cancer therapy, and molecular biology. Her work explores inflammatory mediators, DNA damage, and therapeutic approaches in liver, brain, and nephrotoxicity contexts. She investigates autophagy, necroptosis, and novel strategies like resveratrol nano-formulations for ovarian cancer. Dr. Kadry also studies molecular pathways in gastric and prostate cancers, including miRNA-lncRNA signaling and CRISPR-Cas9 applications. Other interests involve genetic mutations in leukemia, drug-delivery systems, and nanotechnology for breast cancer. Her contributions bridge diagnostics, therapeutic innovations, and cellular mechanisms in oncology and toxicology. 🔬✨

 

Publication Top Notes

  • Inflammatory mediators-induced DNA damage in liver and brain injury: Therapeutic approach of 5-Methoy-N-acetyltryptamine – 2024, Toxicology Reports 🧬
  • Necroptosis and autophagy in cisplatinum-triggered nephrotoxicity: Novel insights regarding prognostic and diagnostic potential – 2024, Toxicology Reports 🧪
  • Resveratrol-based nano-formulations as a therapeutic strategy for ovarian carcinoma: Autophagy and SIRT-1 signaling – 2024, Cancer Nanotechnology 💊
  • miR-122-IGF-1R signaling allied with dysregulated lncRNA MALAT-1 in gastric carcinoma – 2024, Toxicology Reports 🔬 (Cited by: 1)
  • Reciprocal crosslink among MeCP2/BDNF/CREB signaling in autism spectrum disorder – 2024, Toxicology Reports 🧠
  • CRISPR-Cas9 genome and lncRNAs for prostate cancer therapy via liposomal compounds – 2024, PLoS ONE 🧬 (Cited by: 1)
  • Collaboration of Hprt/K-RAS/c-Myc mutation in T-lymphocytic leukemia oncogenesis – 2024, Future Science OA 🧪 (Cited by: 1)
  • Thioctic acid shield against lipopolysaccharide depression and endoplasmic stress – 2024, Future Science OA 🧫
  • Titanium dioxide nanostructure-loaded Adriamycin in breast cancer therapy – 2024, Future Science OA 🎗️ (Cited by: 1)
  • Alleviation of doxorubicin adverse effects via drug-delivery systems – 2024, Therapeutic Delivery 🚑

 

Hanna Danylovych | Biochemistry Award | Best Researcher Award

Posted on by ScienceFather

Dr. Hanna Danylovych | Biochemistry Award | Best Researcher Award

Dr. Hanna Danylovych, Palladin Institute of Biochemistry of National academy Sciences of Ukraine, Ukraine

Dr. Hanna V. Danylovych 🇺🇦, born on May 20, 1974, in Kyiv, is a distinguished Ukrainian biochemist. She earned her Master’s in Biology from the National University of Kyiv-Mohyla Academy in 1999 and has since been a Senior Scientist at the O.V. Palladin Institute of Biochemistry, focusing on muscle biochemistry. Dr. Danylovych completed her Ph.D. in 2006 and her Doctorate in 2022, specializing in nitric oxide biosynthesis in smooth muscle mitochondria 🧬. Her research, published in over 70 articles, explores calcium transport and nitric oxide’s regulatory roles. Awarded the Palladin Award in 2023, she’s recognized for her contributions to biochemistry 🏆.

 

Publication profile

Google Scholar

Education 🎓

Hanna V. Danylovych, born on May 20, 1974, in Kyiv, graduated with a Master’s in Biology from the National University of Kyiv-Mohyla Academy in 1999.

Achievements and Awards 🏆

Dr. Danylovych received the Palladin Award in 2023 for her exceptional contributions to biochemistry and was recognized for her publication in the BioTechnologia Journal in 2018.

 

Research Focus

Dr. Hanna V. Danylovych’s research primarily focuses on biochemistry, specifically the biochemical mechanisms in smooth muscle cells 🧬. Her studies explore how nitric oxide and calcium ions influence the bioenergetics and homeostasis of these cells. She investigates nitric oxide biosynthesis in mitochondria and its regulatory effects on calcium transport and mitochondrial function 🧫. Her work also includes examining the impact of calix[4]arenes as potential modulators of mitochondrial calcium transport systems. Dr. Danylovych’s research has profound implications for understanding and regulating the contractile functions of smooth muscles and cellular energy dynamics ⚡.

Publication Top Notes